BioCentury
ARTICLE | Company News

Sucampo launches tender offer to acquire R-Tech Ueno

August 27, 2015 12:36 AM UTC

Sucampo Pharmaceuticals Inc. (NASDAQ:SCMP) launched a tender offer to acquire R-Tech Ueno Ltd. (JASDAQ:4573) for Y33 billion ($273.9 million).

R-Tech manufactures constipation drug Amitiza lubiprostone for Sucampo and its commercialization partners including Takeda Pharmaceutical Co. Ltd. (Tokyo:4502), Mylan N.V. (NASDAQ:MYL) and Harbin Gloria Pharmaceuticals Co. Ltd. (SZSE:002437). Its pipeline includes candidates in ophthalmology, gastroenterology, autoimmune/inflammatory disease and oncology. ...